Remove Compliance Remove Pharmaceutical Remove Programs Remove Safety
article thumbnail

Aurora Cannabis And Ethypharm Deliver First Shipment To French Medical Marijuana Patients

Cannabis Law Report

.’s (NASDAQ: ACB ) (TSX: ACB ) subsidiary Aurora Germany GmbH and Ethypharm have delivered their initial shipment of cannabis to the French medical cannabis pilot program. “By demonstrating a deep commitment to compliance and focus on product quality, we won three of the nine available tenders. .

Patients 105
article thumbnail

How Does Cannabis Legalization Impact Health, Equity, and Economy in Michigan?

MMJ Recs

Efforts to promote equity in the cannabis industry include initiatives such as social equity programs and the expungement of past cannabis-related convictions, aiming to provide opportunities for inclusion and economic empowerment. The focus is on rectifying past injustices and ensuring fair opportunities in the emerging cannabis industry.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Marijuana as Schedule III: Woe is Me?

Canna Law Blog

All of those clients have to deal with a myriad of healthcare law and regulatory issues under both federal and state law, and the cost of compliance is not cheap. The center doesn’t actually test drugs itself, although it does conduct limited research in the areas of drug quality, safety, and effectiveness standards.

article thumbnail

Regulatory Affairs Associate MCS Associates Mississauga, ON

Cannabis Law Report

JOB DESCRIPTION: Prepare, coordinate and supervise regulatory submissions for NHPs, pharmaceuticals and cosmetic products. Review product conformance and assure compliance. Develop and conduct programs to maintain quality standards of raw materials and finished products. REQUIREMENTS: B.Sc REQUIREMENTS: B.Sc

article thumbnail

Finding Hope: MMJ’s Impact on Maryland Communities

MMJ Recs

The community impact is visible in several key areas: Healthcare Advancements MMJ has expanded the range of treatment options available to patients, offering an alternative to conventional pharmaceuticals. The state’s program has evolved to meet the needs of patients and the demands of the industry.

article thumbnail

atai Life Sciences launches InnarisBio, in partnership with the University of Queensland, with the aim to develop a more effective nose-to-brain delivery method for atai’s platform of mental health therapeutic programs

Cannabis Law Report

The sol-gel technology is designed to deliver pharmaceutical compounds as a liquid at room temperature which becomes a gel at body temperature. UniQuest is a partner on the MRFF Biomedical Translation Bridge (BTB) Program with MTPConnect. Under the terms of the license, InnarisBio will receive exclusive rights in their desired fields.

article thumbnail

SICPA/HARRIS POLL CANNABIS LABELING SURVEY RESULTS

Cannabis Law Report

A new nationwide study commissioned by SICPA North America, a leading provider of regulatory compliance solutions, and conducted online by The Harris Poll among over 2,000 U.S. adults shows broad support for securely labeling cannabis products to verify their legitimacy and safety in the marketplace.

Safety 52